Revolution Medicines, Inc. (NASDAQ:RVMD) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight research firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price […]

Leave a Reply

Your email address will not be published.

Previous post Corteva, Inc. (NYSE:CTVA) Receives $64.65 Average Price Target from Analysts
Next post Bank of Hawaii Co. (NYSE:BOH) Receives Consensus Recommendation of “Reduce” from Analysts